SCHEMBL21872268

SCHEMBL21872268

F/C=C/CN1CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 3/20 0.41
TSHR P16473 2/20 0.41
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
KEAP1 Q14145 1/20 0.38
HSD17B10 Q99714 3/20 0.37
ALOX15 P16050 2/20 0.35
GLA P06280 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
CYP2A13 Q16696 1/20 0.34
CYP2C9 P11712 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CXCR4 P61073 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10748084 0.92 KDM4E (0.44) KDM4EALDH1A1TSHRUSP2SMN1; SMN2
SCHEMBL10748936 0.92 KDM4E (0.44) KDM4EALDH1A1TSHRUSP2SMN1; SMN2
SCHEMBL4424654 0.81 KDM4E (0.39) KDM4EALDH1A1TSHRUSP2SMN1; SMN2
SCHEMBL1467291 0.81 KDM4E (0.45) KDM4EALDH1A1TSHRUSP2SMN1; SMN2
SCHEMBL4417627 0.81 KDM4E (0.39) KDM4EALDH1A1TSHRUSP2SMN1; SMN2
SCHEMBL23298992 0.81 SMN1; SMN2 (0.45) KDM4EALDH1A1TSHRUSP2SMN1; SMN2
SCHEMBL3307823 0.81 KDM4E (0.46) KDM4EALDH1A1TSHRUSP2SMN1; SMN2
SCHEMBL16666824 0.81 ALDH1A1 (0.39) KDM4EALDH1A1TSHRUSP2SMN1; SMN2
SCHEMBL16666821 0.81 ALDH1A1 (0.39) KDM4EALDH1A1TSHRUSP2SMN1; SMN2
SCHEMBL17284617 0.81 KDM4E (0.39) KDM4EALDH1A1TSHRUSP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3808743-A1 HIV REPLICATION INHIBITING PYRIMIDINES Janssen Pharmaceutica NV (BE) 2021-04-21 EP disclosed
EP-2298761-B1 HIV INHIBITING PYRIMIDINES DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2020-03-25 EP disclosed